Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls von Pedersen, Katrina S, Bamlet, William R, Oberg, Ann L, de Andrade, Mariza, Matsumoto, Martha E, Tang, Hui, Thibodeau, Stephen N, Petersen, Gloria M, Wang, Liang

Volltext

Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling von MCWILLIAMS, Robert R, WIEBEN, Eric D, RABE, Kari G, PEDERSEN, Katrina S, YANHONG WU, SICOTTE, Hugues, PETERSEN, Gloria M

Volltext

Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study von Pedersen, Katrina S., Kim, George P., Foster, Nathan R., Wang-Gillam, Andrea, Erlichman, Charles, McWilliams, Robert R.

Volltext

FDG-PET/MRI for Nonoperative Management of Rectal Cancer: A Prospective Pilot Study von Ince, Semra, Itani, Malak, Henke, Lauren E, Smith, Radhika K, Wise, Paul E, Mutch, Matthew G, Glasgow, Sean C, Silviera, Matthew L, Pedersen, Katrina S, Hunt, Steven R, Kim, Hyun, Fraum, Tyler J

Volltext

Risk of nonalcoholic fatty liver disease and associations with gastrointestinal cancers von McHenry, Scott, Zong, Xiaoyu, Shi, Mengyao, Fritz, Cassandra D.L, Pedersen, Katrina S., Peterson, Linda R., Lee, Jeffrey K., Fields, Ryan C., Davidson, Nicholas O., Cao, Yin

Volltext

Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancer von Li, Chen, Ferro, Ana, Mhatre, Shivani K., Lu, Danny, Lawrance, Marcus, Li, Xiao, Li, Shi, Allen, Simon, Desai, Jayesh, Fakih, Marwan, Cecchini, Michael, Pedersen, Katrina S., Kim, Tae You, Reyes-Rivera, Irmarie, Segal, Neil H., Lenain, Christelle

Volltext

Oncology Trainee Perceptions of the Prior Authorization Process: A National Survey von Kim, Hyun, Srivastava, Amar, Gabani, Prashant, Kim, Elizabeth, Lee, Hohyun, Pedersen, Katrina S.

Volltext

BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial von Bockorny, Bruno, Semenisty, Valerya, Macarulla, Teresa, Borazanci, Erkut, Wolpin, Brian M., Stemmer, Salomon M., Golan, Talia, Geva, Ravit, Borad, Mitesh J., Pedersen, Katrina S., Park, Joon Oh, Ramirez, Robert A., Abad, David G., Feliu, Jaime, Muñoz, Andres, Ponz-Sarvise, Mariano, Peled, Amnon, Lustig, Tzipora M., Bohana-Kashtan, Osnat, Shaw, Stephen M., Sorani, Ella, Chaney, Marya, Kadosh, Shaul, Vainstein Haras, Abi, Von Hoff, Daniel D., Hidalgo, Manuel

Volltext

ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel Adenocarcinoma von Pedersen, Katrina S., Foster, Nathan R., Overman, Michael J., Boland, Patrick M., Kim, Sunnie S., Arrambide, Kathryn A., Jaszewski, Brandy L., Bekaii-Saab, Tanios, Graham, Rondell P., Welch, Jack, Wilson, Richard H., McWilliams, Robert R.

Volltext

Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma von Grierson, Patrick M, Tan, Benjamin, Pedersen, Katrina S, Park, Haeseong, Suresh, Rama, Amin, Manik A, Trikalinos, Nikolaos A, Knoerzer, Deborah, Kreider, Brent, Reddy, Anupama, Liu, Jingxia, Der, Channing J, Wang-Gillam, Andrea, Lim, Kian-Huat

Volltext

Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors von Goldman, Jonathan W., Piha-Paul, Sarina A., Curti, Brendan, Pedersen, Katrina S., Bauer, Todd M., Groenland, Stefanie L., Carvajal, Richard D., Chhaya, Vaishali, Kirby, Gray, McGlinchey, Kelly, Hammond, Scott A., Streicher, Katie, Townsley, Danielle M., Chae, Young Kwang, Voortman, Jens, Marabelle, Aurelien, Powderly, John

Volltext

Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I study von Pedersen, Katrina S., Grierson, Patrick M., Picus, Joel, Lockhart, A. Craig, Roth, Bruce J., Liu, Jingxia, Morton, Ashley, Chan, Emily, Huffman, Jesse, Liang, Chris, Wang-Gillam, Andrea, Tan, Benjamin

Volltext

CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations von McWilliams, Robert R, Wieben, Eric D, Chaffee, Kari G, Antwi, Samuel O, Raskin, Leon, Olopade, Olufunmilayo I, Li, Donghui, Highsmith, Jr, W Edward, Colon-Otero, Gerardo, Khanna, Lauren G, Permuth, Jennifer B, Olson, Janet E, Frucht, Harold, Genkinger, Jeanine, Zheng, Wei, Blot, William J, Wu, Lang, Almada, Luciana L, Fernandez-Zapico, Martin E, Sicotte, Hugues, Pedersen, Katrina S, Petersen, Gloria M

Volltext

BRCA2‐associated pancreatic cancer and current screening guidelines von Kasi, Pashtoon Murtaza, Pedersen, Katrina S., McWilliams, Robert R.

Volltext

Preemptive Versus Reactive Topical Clobetasol for Regorafenib‐Induced Hand‐Foot Reactions: A Preplanned Analysis of the ReDOS Trial von Jatoi, Aminah, Ou, Fang‐Shu, Ahn, Daniel H., Zemla, Tyler J., Le‐Rademacher, Jennifer G., Boland, Patrick, Ciombor, Kristen K., Jacobs, Nisha L., Pasche, Boris, Cleary, James M., McCune, Jeannine S., Pedersen, Katrina S., Barzi, Afsaneh, Chiorean, E. Gabriela, Heying, Erica N., Lenz, Heinz‐Josef, Sloan, Jeff A., Grothey, Axel, Lacouture, Mario E., Bekaii‐Saab, Tanios

Volltext

Understanding Suboptimal Response to Immune Checkpoint Inhibitors von Zhu, Mojun, Zhang, Henan, Pedersen, Katrina S., Foster, Nathan R., Jaszewski, Brandy L., Liu, Xin, Hirdler, Jacob B., An, Zesheng, Bekaii‐Saab, Tanios S., Halfdanarson, Thorvardur R., Boland, Patrick M., Yan, Yiyi, Hubbard, Joleen H., Ma, Wen Wee, Yoon, Harry H., Revzin, Alexander, Fernandez‐Zapico, Martin E., Overman, Michael J., McWilliams, Robert R., Dong, Haidong

Volltext

Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer von Regenbogen, Thomas, Chen, Ling, Trinkaus, Kathryn, Wang-Gillam, Andrea, Tan, Benjamin R, Amin, Manik, Pedersen, Katrina S, Park, Haeseong, Suresh, Rama, Lim, Kian-Huat, Ratchford, Emily, Brown, Amberly, Lockhart, A Craig

Volltext

Abstract CT167: First-in-human clinical trial of SC-006, a RNF43 targeted antibody-drug conjugate, as a monotherapy and in combination with budigalimab in patients with advanced co... von Pedersen, Katrina S., Mahipal, Amit, Cercek, Andrea, Ulahannan, Susanna, Rossi, Michael, Fong, Abraham, Brickman, Daniel, Bendell, Johanna

Volltext

Mo1258: EVALUATING THE IMPACT OF ENDOSCOPIC ULTRASOUND IN THE MULTIDISCIPLINARY MANAGEMENT OF PANCREATIC CYSTIC LESIONS: A NESTED, CASE CONTROL STUDY von Genere, Juan Reyes, Rengarajan, Arvind, Lang, Gabriel, Kushnir, Vladimir, Hollander, Thomas, Hawkins, William G., Khan, Adeel, Pedersen, Katrina S., Lim, Kian-Huat, Hoegger, Mark, Shetty, Anup, Mellnick, Vincent, Altayar, Osama, Das, Koushik K.

Volltext

ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel Adenocarcinoma von Pedersen, Katrina S., Foster, Nathan R., Overman, Michael J., Boland, Patrick M., Kim, Sunnie S., Arrambide, Kathryn A., Jaszewski, Brandy L., Bekaii-Saab, Tanios, Graham, Rondell P., Welch, Jack, Wilson, Richard H., Mcwilliams, Robert R.

Volltext